Integer (NYSE:ITGR) Issues Earnings Results

Integer (NYSE:ITGR - Get Free Report) released its quarterly earnings data on Thursday. The medical equipment provider reported $1.43 EPS for the quarter, topping the consensus estimate of $1.36 by $0.07, Briefing.com reports. The firm had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. The company's quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.27 earnings per share. Integer updated its FY24 guidance to $5.24-5.43 EPS and its FY 2024 guidance to 5.240-5.430 EPS.

Integer Trading Up 0.2 %

Shares of ITGR traded up $0.31 during trading hours on Thursday, reaching $126.84. 524,924 shares of the company traded hands, compared to its average volume of 312,988. Integer has a 12 month low of $69.40 and a 12 month high of $133.53. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73. The company's fifty day moving average price is $127.37 and its two-hundred day moving average price is $120.86. The company has a market capitalization of $4.25 billion, a price-to-earnings ratio of 43.86, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08.

Insider Buying and Selling

In other Integer news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the sale, the director now directly owns 2,280 shares of the company's stock, valued at approximately $272,824.80. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.00% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. KeyCorp lifted their price target on Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 15th. Bank of America upped their price target on shares of Integer from $135.00 to $145.00 and gave the company a "buy" rating in a report on Tuesday, October 1st. Benchmark raised their price target on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Monday. Oppenheimer assumed coverage on shares of Integer in a research note on Tuesday, July 16th. They set an "outperform" rating and a $135.00 price objective for the company. Finally, Citigroup raised their target price on Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $140.14.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.